Subcutaneous vs. Intravenous ORENCIA® Administration
ORENCIA® (abatacept) is the first and only biologic therapy for rheumatoid arthritis (RA) where both ORENCIA® intravenous (IV) and subcutaneous (SC) formulations have been FDA-approved with comparable clinical efficacy and safety profiles.